Public Health Surveillance: Preparing for the Future Pdf Icon[PDF – 40 Pages]
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
OCCUPATIONAL MEDICINE PROGRAM HANDBOOK October 2005
U.S. DEPARTMENT OF THE INTERIOR OFFICE OF OCCUPATIONAL HEALTH AND SAFETY OCCUPATIONAL MEDICINE PROGRAM HANDBOOK October 2005 This Occupational Medicine Program Handbook was prepared by the U.S. Department of the Interior’s Office of Occupational Health and Safety, in consultation with the U.S. Office of Personnel Management and the U.S. Public Health Service’s Federal Occupational Health service. This edition of the Handbook represents the continuing efforts of the contributing agencies to improve occupational health services for DOI employees. It reflects the comments and suggestions offered by users over the years since it was first introduced, and addresses the findings, concerns, and recommendations summarized in the final report of a program review completed in 1994 by representatives of the Uniformed Services University of the Health Sciences. That report, entitled “A Review of the Occupational Health Program of the United States Department of the Interior,” was prepared by Margaret A.K. Ryan, M.D., M.P.H., Gail Gullickson, M.D., M.P.H., W. Garry Rudolph, M.D., M.P.H., and Elizabeth Odell. The report led to the establishment of the Department’s Occupational Health Reinvention Working Group, composed of representatives from the DOI bureaus and operating divisions. The recommendations from the Reinvention Working Group final report, published in May of 1996, were addressed and are reflected in what became this Handbook. First published in 1997, the Handbook underwent a major update in July, 2000. This 2005 version of the Handbook incorporates the updates and enhancements that have been made in DOI policies and occupational medicine practice since the last edition. -
Small Drinking Water Systems Project
Strong evidence, stronger public health Small Drinking Water-borne Disease Outbreaks in Water Systems Canadian Small Drinking Water Systems Project Hannah Moffatt, Sylvia Struck Report Highlights Information about Canadian drinking water systems and past water-borne disease outbreaks is incomplete and non-standardized. Standard definitions and coordinated surveillance systems for water-borne disease outbreaks would help inform policy and practice. A relatively high proportion of past water-borne disease outbreaks in Canada are estimated to have occurred in small drinking water systems serving populations of 5,000 people or less. Water-borne disease outbreaks in small drinking water systems are often the result of a combination of water system failures; contributing factors often include a lack of source water protection and inadequate drinking water treatment. Analyses suggest small drinking water systems face challenges associated with infrastructure, technology, and financial constraints. Investments in drinking water systems and operator training have the potential to reduce the burden of water-borne disease in Canada. Executive Summary Generally, Canadians have access to safe and secure drinking water. However, as demonstrated by the events of Walkerton in 2000, the exception can be tragic. Outbreaks of water-borne disease are preventable, yet evidence-informed policy and practice is hampered, in part, by our limited knowledge of drinking water systems that experience outbreaks and the factors that contribute to outbreaks in Canada. There is no national surveillance system for systematic collection of water-borne disease outbreak data. Investigating past water-borne disease outbreaks is a valuable approach to collect information to inform practice and policy. Investigations of water-borne disease outbreaks are challenging because the outbreak events are rare, the pathogenic agents involved may be transmitted via multiple routes (e.g., person to person, food-borne, as well as water-borne), and gastrointestinal illnesses are frequently under-reported. -
Federal Register/Vol. 84, No. 97/Monday, May 20, 2019/Proposed Rules
22756 Federal Register / Vol. 84, No. 97 / Monday, May 20, 2019 / Proposed Rules rents, or royalties received or accrued (iii) Anti-abuse rule. Paragraphs § 1.958–2 Constructive ownership of from a foreign corporation as received or (f)(2)(iv)(B)(1) and (3) of this section stock. accrued from a controlled foreign apply to taxable years of controlled * * * * * corporation payor if a principal purpose foreign corporations ending on or after (d) * * * of the use of an option to acquire stock May 17, 2019, and to taxable years of (1) * * * Except as otherwise or an equity interest, or an interest United States shareholders in which or provided in paragraph (d)(2) of this similar to such an option, that causes with which such taxable years end, with section and § 1.954–1(f)— the foreign corporation to be a respect to amounts that are received or * * * * * controlled foreign corporation payor is accrued by a controlled foreign (e) * * * Except as otherwise to qualify dividends, interest, rents, or corporation on or after May 17, 2019 to provided in § 1.954–1(f), if any person royalties paid by the foreign corporation the extent the amounts are received or has an option to acquire stock, such for the section 954(c)(6) exception. For accrued in advance of the period to stock shall be considered as owned by purposes of this paragraph which such amounts are attributable such person. * * * (f)(2)(iv)(B)(2), an interest that is similar with a principal purpose of avoiding the * * * * * to an option to acquire stock or an application of paragraph (f)(2)(iv)(B)(1) (h) Applicability date. -
Globalization and Infectious Diseases: a Review of the Linkages
TDR/STR/SEB/ST/04.2 SPECIAL TOPICS NO.3 Globalization and infectious diseases: A review of the linkages Social, Economic and Behavioural (SEB) Research UNICEF/UNDP/World Bank/WHO Special Programme for Research & Training in Tropical Diseases (TDR) The "Special Topics in Social, Economic and Behavioural (SEB) Research" series are peer-reviewed publications commissioned by the TDR Steering Committee for Social, Economic and Behavioural Research. For further information please contact: Dr Johannes Sommerfeld Manager Steering Committee for Social, Economic and Behavioural Research (SEB) UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) World Health Organization 20, Avenue Appia CH-1211 Geneva 27 Switzerland E-mail: [email protected] TDR/STR/SEB/ST/04.2 Globalization and infectious diseases: A review of the linkages Lance Saker,1 MSc MRCP Kelley Lee,1 MPA, MA, D.Phil. Barbara Cannito,1 MSc Anna Gilmore,2 MBBS, DTM&H, MSc, MFPHM Diarmid Campbell-Lendrum,1 D.Phil. 1 Centre on Global Change and Health London School of Hygiene & Tropical Medicine Keppel Street, London WC1E 7HT, UK 2 European Centre on Health of Societies in Transition (ECOHOST) London School of Hygiene & Tropical Medicine Keppel Street, London WC1E 7HT, UK TDR/STR/SEB/ST/04.2 Copyright © World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases 2004 All rights reserved. The use of content from this health information product for all non-commercial education, training and information purposes is encouraged, including translation, quotation and reproduction, in any medium, but the content must not be changed and full acknowledgement of the source must be clearly stated. -
Water-Borne Diseases
Bronx Community Health Dashboard: Communicable Disease Last Updated: 9/24/2019 See last slide for more information about this project. 1 Food- & Water-Borne Diseases Data note: All data are reported by labs and are not a measure of true incidence in the population as not all people seek care or are tested. 2 Overall, salmonella rates have declined in all five boroughs Bronx Brooklyn Manhattan Queens Staten Island 25 Salmonella is a group of bacteria that is one of the most common causes of food poisoning in the U.S. Most infected people develop diarrhea, fever, and abdominal cramps 12 to 72 hours after infection. The illness 20 typically lasts 4 to 7 days, and most people recover without treatment. However, in some people, the diarrhea may be so severe that they need to be hospitalized. 16.0 16.2 15 15.5 13.5 12.6 13.1 12.3 10 10.1 adjusted rate per adjusted 100,000 Salmonella 7.0 - Age 5 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 3 Data source: New York City Department of Health and Mental Hygiene Communicable Disease Surveillance Data, 2000-2017. Salmonella rates are above average in the Morrisania, Pelham, and Fordham areas of the Bronx compared to New York City overall 101 101 Kingsbridge 103 102 16 15.5 102 Northeast Bronx 14.4 13.9 103 Fordham 105 104 12.8 104 Pelham 106 105 Crotona 107 12 106 Morrisania 10.3 10.1 107 Mott Haven 8.8 8 4 adjusted rate per adjusted 100,000 Salmonella - 0 Age 4 Data source: New York City Department of Health and Mental Hygiene Communicable Disease Surveillance Data, 2017. -
Principles and Practice of Public Health Surveillance
r I P82 " ,Ji<liTin' S PB93-101129 1994 I" PRINCIPLES AND PRACTICE OF PUBLIC HEALTH SURVEILLANCE CENTERS FOR DISEASE CONTROL ATLANTA, GA AUG 92 U.S. DEPARTMENT OF COMMERCE National Technical Information Service \\ P3S3-1C112S Principles and Practice of Public Health Surveillance Steven M. Teutsch R. Elliott Churchill Editors BLDG 10 S. DEPARTMENT OF HEALTH & HUMAN SERVICES CDC Public Health Service Health Lftwy Paiuam »*» Epidemiology Program Office Lane.P.n".. 5600 Fishars Centers for Disease Control 20857 August 1992 Us* of trade naaaa is for identification only and does not constitute endorsement by the Public Health Service or the Centers for Disease Control. Form Approved REPORT DOCUMENTATION PAGE OMB No. 0704-0188 Public reporting burden for this collection of information is estimated to average 1 hour oer response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information Send comments regarding this burden estimate or any other aspect of this 5 collection of information, including suggestions for reducing this burden, to Washington Headouarters Services. Directorate for Information Operations and Reports, 1215 Jefferson L ' " *— Dav — '. andto the Officeof Managementand Budget. Paperwork Reduction Project (0704-0188), Washington. DC 20503 PB9 3-10 1129 2. REPORT DATE 3. REPORT TYPE AND DATES COVERED August 1992 Final 4. TITLE AND SUBTITLE 5. FUNDING NUMBERS Principles and Practice of Surveillance None 6. AUTHOR(S) Teutsch, Steven M. and CHoif.) 4il-^^o Churchill, R. Elliott, Editors 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER Epidemiology Program Office Centers for Disease Control Mail stop C08 Atlanta, GA 30333 None 9. -
2010 Ca-1 Tutorial Textbook
Name:_______________________ 2010 CA-1 TUTORIAL TEXTBOOK 4th Edition STANFORD UNIVERSITY MEDICAL CENTER DEPARTMENT OF ANESTHESIOLOGY Aileen Adriano, M.D. KtKate EllbEllerbroc k, MDM.D. Becky Wong, M.D. TABLE OF CONTENTS Introduction…………………………………………………………………….ii Acknowledgements…………………………………………………………….iii Contributors…………………………………………………………………….iv Key Points and Expectations…………………………………………………...v Goals of the CA-1 Tutorial Month……………………………………………..vi Checklist for CA-1 Mentorship Intraoperative Didactics………………………vii CA-1 Mentorship Intraoperative Didactic Lectures Standard Monitors………………………………………………..1 Inhalational Agents…………………………………………….....4 MAC and Awareness……………………………………………..7 IV Induction Agents……………………………………………..10 Rational Opioid Use……………………………………………..13 Intraoperative Hypotension & Hypertension……………………16 Neuromuscular Blocking Agents………………………………..19 Difficult Airway Algorithm……………………………………..23 Fluid Management ……………………………………………...27 Transfusion Therapy…………………………………………….31 Hypoxemia…………………………………………………........35 Electrolyte Abnormalities……………………………………….39 Hypothermia & Shivering………………………………….……44 PONV……………………………………………………………47 Extubation Criteria & Delayed Emergence……………….….…50 Laryngospasm & Aspiration…………………………………….53 Oxygen Failure in the OR……………………………………….56 Anaphylaxis……………………………………………………..59 ACLS…………………………………………………….………62 Malignant Hyperthermia………………………………………...65 Perioperative Antibiotics………………………………………..69 Cognitive Aids Reference Slides………………………………..72 i INTRODUCTION TO THE CA-1 TUTORIAL MONTH We want to welcome you as the -
Redundancy Unite Guide for Members Contents
Legal services Right by your side Redundancy Unite guide for members Contents Introduction 3 What is redundancy? 4 Lay-off and short term working Consultation 5 Re-structures and changes to terms and conditions When should consultation begin? Disclosure of information Scope of Consultation Requirement to complete the HR1 form Insolvency Failure to inform and consult Protective Award Representative’s role 8 Time off for representatives Facilities for representatives Statutory protection for representatives Selection for redundancy 9 Discrimination Automatically unfair selection criteria Notice 11 Time off to look for work Redundancy pay 12 Workers with no right to redundancy pay Calculating redundancy pay A ‘weeks’ pay Written statement Redundancy payments and tax State benefits Alternative employment 14 Maternity Leave Trial period Unfair dismissal Time limit COVID 19 16 Corona Virus Job Retention Scheme Section 188 consultation Selection for Redundancy Calculation of Statutory Redundancy Pay Calculation of Statutory Notice Pay Introduction Redundancy has become an all too depressing feature of the modern economic landscape. Globalisation, increased competition, technological change, government cuts have all contributed to the continuing tide of job losses. At least 109,000 workers lost their jobs in the UK through redundancy in 2019. Redundancy affects not only individuals, but their families and local communities as well. For this reason Unite seeks to use all means possible to safeguard jobs. Our aim is always to reach agreements which -
Complementarity in Public Health Systems: Using Redundancy As a Tool of Public Health Governance
Annals of Health Law Volume 22 Issue 2 Special Edition 2013 Article 4 2013 Complementarity in Public Health Systems: Using Redundancy as a Tool of Public Health Governance Lance Gable Benjamin Mason Meier Follow this and additional works at: https://lawecommons.luc.edu/annals Part of the Health Law and Policy Commons Recommended Citation Lance Gable & Benjamin M. Meier Complementarity in Public Health Systems: Using Redundancy as a Tool of Public Health Governance, 22 Annals Health L. 224 (2013). Available at: https://lawecommons.luc.edu/annals/vol22/iss2/4 This Article is brought to you for free and open access by LAW eCommons. It has been accepted for inclusion in Annals of Health Law by an authorized editor of LAW eCommons. For more information, please contact law- [email protected]. Gable and Meier: Complementarity in Public Health Systems: Using Redundancy as a T Complementarity in Public Health Systems: Using Redundancy as a Tool of Public Health Governance Lance Gable* & Benjamin Mason Meier** I. INTRODUCTION Modem notions of public health law embody an astounding complexity. Layers of authority arise from the accretion of legislative, regulatory, and common law developments over many years and across many subjects and jurisdictions.' As recognition of the variety and interconnectedness of public health threats has grown to encompass both proximal and distal determinants of health, the application and relevance of law has evolved to address these challenges.2 Traditional understandings of public health law focused primarily on alleviation -
Week 14 Part II Vaccine Preventable Disease Surveillance Welcome To
Slide 1 Welcome to Week 14 Part II on Vaccine Preventable Disease Week 14 Part II Surveillance. In this part, we will discuss immunization Vaccine Preventable coverage as an indicator for vaccine preventable disease Disease Surveillance surveillance, on a global scale. To accomplish this, we will use the most updated information from the World Health Organization (W.H.O.). ©DJH2013 Slide 2 The following slides were excerpted from a presentation entitled “Progress Towards Global Immunization Goals-2012”. This is a summary presentation of key indicators from the World Health Organization which was last updated in July 2013. This is the most current available information at the time of this lecture. Source: http://www.who.int/immunization_monitoring/data/SlidesGlobalI mmunization.pdf http://www.who.int/immunization_monitorin ©DJH2013 g/data/SlidesGlobalImmunization.pdf Slide 3 This graph shows the % coverage with diphtheria, tetanus, & pertussis (DTP3) vaccine (from 0-100%) on the “y” axis and the year (from 1980-2012) on the “x” axis. The yellow bars represent the global percentages. The different colored lines represent the 6 regions designated by the W.H.O.: African, American, Eastern Mediterranean, European, Southeast Asian, and Western Pacific. In 2012, coverage for this vaccine series on a global scale was 83%. In that same year, the Western ©DJH2013 Pacific and European Regions, followed by the American ©DJH2013 Region, had the highest % coverage for this vaccine. Slide 4 This pie chart divides the 6 regions by the numbers of infants not immunized for diphtheria toxoid, tetanus toxoid and pertussis vaccine (DTP3). In 2012, the total number of infants not immunized for DTP3 was 22.6 million. -
Hazard Analysis Fail-Safe Design Redundancy
Fact Sheet #15 – December 2020 Revision: Five (Sample Posting Below with Downloadable Copy at the bottom of the document) Northeastern University Procedure For Running Unattended Equipment And Experiments Background Equipment and experiments that run unattended during the day and overnight have the potential of causing significant problems and harm to University personnel, facilities, and equipment. Although we discourage this practice as much as possible, particularly when hazardous substances are involved, we do recognize there is a need to run these experiments at certain times. The following procedures should be used as guidance when carrying out such experiments. Hazard Analysis Anyone considering running an experiment unattended should consider the possible hazards that could occur as a result of failures, malfunctions, operational methods, environments encountered, maintenance error and operator error. These hazards can be identified by looking at the system as a whole and identifying which failure(s) could occur. Some examples include: a) Water If water was suddenly interrupted or a hose pulled out or burst, would the system overheat, flood the laboratory, or cause some other problem? b) Signage If appropriate signage was not used, could someone mistake the containers or turn a switch that was intended to remain open/closed? c) Power Interruption If power was suddenly interrupted would the system or safety features for the system also be shut down? Fail-Safe Design Experiments must be designed so that they are “fail-safe”, which means that they will prevent one malfunction from propagating other failures. Fail-safe designs ensure that a failure will leave the experiment unaffected or will convert it to a state in which no injury or damage will occur. -
(IDSR) Technical Guidelines
CONTENTS This booklet introduces all 11 sections of the Integrated Disease Surveillance and Response (IDSR) Technical Guidelines THIRD EDITION World Health Organization Centers for Disease Control and Prevention Regional Office for Africa Center for Global Health WHO Health Emergency Programme Division of Public Health Systems and Workforce Development Brazzaville, Republic of Congo Atlanta, Georgia, USA Integrated Disease Surveillance and Response Technical Guidelines, Booklet One: Introduction Section WHO/AF/WHE/CPI/05, 2019 © WHO Regional Office for Africa 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc- sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.